Ignite Creation Date:
2024-05-06 @ 7:45 PM
Last Modification Date:
2024-10-26 @ 3:13 PM
Study NCT ID:
NCT06126146
Status:
COMPLETED
Last Update Posted:
2024-06-03
First Post:
2023-11-07
Brief Title:
An Observational Study to Assess Participant-Reported Real-World Experience of Risankizumab On-body Injector OBI for the Treatment of Crohns Disease in Adult Participants in the United Kingdom UK
Sponsor:
Organization:
AbbVie
Study Design
Study Type:
OBSERVATIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
None
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
None
Bio Spec Description:
None
Enrollment Count:
53
Enrollment Type:
ACTUAL
Design Primary Purpose:
Design Masking:
Phases:
Observational Models:
| Name |
|---|
| Cohort |
Time Perspective List:
Clinical Trial Statuses
| Name |
|---|
| 100812 |
Who Masked List: